Ekso Bionics (NASDAQ: EKSO) reported Q2 EPS of ($0.23), $0.01 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $3.5 million versus the consensus estimate of $3.49 million.

For earnings history and earnings-related data on Ekso Bionics (EKSO) click here.